Press release from Business Wire
ARIAD Announces Webcast of Its Annual Stockholders Meeting
Thursday, June 10, 2010
ARIAD Announces Webcast of Its Annual Stockholders Meeting07:35 EDT Thursday, June 10, 2010 CAMBRIDGE, Mass. (Business Wire) -- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that its Annual Meeting of Stockholders on June 24, 2010 will be webcast live and can be accessed by visiting the investor relations section of the Company's website at http://investor.ariad.com. The annual meeting will take place at 10:00 a.m. (ET) at the Company's offices in Cambridge, Massachusetts and will include an overview of ARIAD and its key programs provided by Harvey J. Berger, M.D., chairman and chief executive officer of ARIAD. A replay will be available on the ARIAD website approximately three hours after the presentation and will be archived for four weeks. To ensure a timely connection to the live webcast, participants should log on to the webcast at least fifteen minutes prior to the scheduled start time. About ARIAD ARIAD's vision is to transform the lives of cancer patients with breakthrough medicines. The Company's mission is to discover, develop and commercialize small-molecule drugs to treat cancer in patients with the greatest and most urgent unmet medical need – aggressive cancers where current therapies are inadequate. ARIAD's lead product candidate, ridaforolimus, is an investigational mTOR inhibitor being developed by Merck Sharpe & Dohme Corp. and is in Phase 3 clinical development in patients with advanced sarcomas. ARIAD's second internally discovered product candidate, AP24534, is an investigational pan-BCR-ABL inhibitor completing Phase 1 clinical development in patients with hematological cancers, notably chronic myeloid leukemia. For additional information about the Company, please visit http://www.ariad.com.